COVID-19 Actuaries Response Group

The Friday Report – Issue 31

Bulletin 90 | Matt Fletcher, Nicola Oliver & John Roberts

COVID-19 is still one of the hottest topics for scientific papers and articles. The COVID‑19 Actuaries Response Group provides a regular Friday update with a summary of the key papers and articles that we’ve looked at recently.

In this report:

  • Trajectories of anxiety and depression
  • Metformin and risk of mortality in patients hospitalised with COVID-19
  • Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City
  • Number of Childhood and Adolescent Vaccinations Administered Before and After the COVID-19 Outbreak in Colorado
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
  • Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions
  • Vaccine updates
  • SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional
  • analysis of infection clusters and outbreaks in England
  • Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study
  • Various data sources
Avatar photo

Matthew Fletcher

Senior Consultant - AON

Matt has over 20 years’ consultancy experience, including over 10 years as a specialist in mortality and longevity. He works in Aon’s Demographic Horizons team, advising insurance companies and pension funds on setting best estimates and evaluating risk for longevity and other demographic assumptions, both in the UK and overseas.

Matt chairs the CMI Self-Administered Pension Schemes (SAPS) Committee, which produces mortality tables that are used extensively in the pensions and insurance industries.

Avatar photo

Nicola Oliver

Director of Life & Health - Medical Intelligence

Nicola is considered a leading expert in Public Health and associated Mortality, Morbidity & Longevity risk.

Areas of specialist knowledge include; public health policy, socioeconomic disparities, impact of risk behaviours on life expectancy & future infectious disease risks.

Nicola supports actuaries from many of the leading consultancies, pension & insurance companies in Europe and the US, with underwriting, annuity pricing, product development as well as internal model calibration to fulfil regulatory requirement.

She leads a small research team within Medical Intelligence and continues to regularly present her work and speak at events for and on behalf of clients and to wider public audiences.

Prior to co-founding Medical Intelligence in 2007, Nicola worked for the NHS for 19 years specialising in Public Health, this followed many years in senior roles in Intensive Care Nursing and Paediatrics.

Nicola trained as a nurse and subsequently studied at Homerton College University of Cambridge, graduating with a PgDip in Neonatal Special and Intensive Care followed up with a BSc (Hons) in Public Health (Specialist Community).

Nicola has also studied Epidemiology with the London School of Hygiene & Tropical Medicine and Statistics.

Avatar photo

John Roberts

Independent Consultant

John is an independent consultant who has spent 37 years in the life industry, including 17 years at Canada Life and more recently 8 years at Zurich Insurance Group, where he was part of the team that established its corporate risk business, now well established in the market. Following that he was Head of the Life Pricing team at Zurich for 5 years, overseeing a wide range of wealth and protection propositions.

At Zurich he helped establish its small pension scheme longevity swap proposition, which involved setting up simultaneous reinsurance transactions to mirror the client contracts. He has most recently continued with this line of interest as a consultant, supporting Lloyds Banking Group in establishing its first longevity swap transactions.

John is a Fellow of the Institute of Actuaries.

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular